Gastrointestinal Cancer Drugs Comprehensive Study by Application (Hospitals, Specialized Cancer Treatment Centers, Clinics, Ambulatory Surgical Centers), Drug Type (Ramucirumab, Docetaxel, Doxorubicin Hydrochloride, Fluorouracil, Others), Therapy (Immunotherapy, Chemotherapy, Targeted Therapy, Sunitinib, Trastuzumab, Imatinib, Hormone Therapy, Adjuvant Chemotherapy, Radiation Therapy, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others) Players and Region - Global Market Outlook to 2027

{reportSlug=global-gastrointestinal-cancer-drugs-market, reportId=58546, mktKeyword=Gastrointestinal Cancer Drugs, cagr=16.00, publishDate=Feb 2024, priceOption2=6800, reportTitle=Gastrointestinal Cancer Drugs Comprehensive Study by Application (Hospitals, Specialized Cancer Treatment Centers, Clinics, Ambulatory Surgical Centers), Drug Type (Ramucirumab, Docetaxel, Doxorubicin Hydrochloride, Fluorouracil, Others), Therapy (Immunotherapy, Chemotherapy, Targeted Therapy, Sunitinib, Trastuzumab, Imatinib, Hormone Therapy, Adjuvant Chemotherapy, Radiation Therapy, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others) Players and Region - Global Market Outlook to 2027, baseYr=2021, totalTableFig=200, priceOption1=3750, forecastYr=2027, noOfPages=242, reportKey=58234, breadcrum=Global (United States, European Union and China) Gastrointestinal Cancer Drugs}